Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Cumulative weight loss is now significant and life-changing for most patients Cardiometabolic markers blood pressure, cholesterol, blood sugar typically showing meaningful improvement Many patients who began with significant mobility issues are moving more freely Psychological benefits becoming evident improved confidence, social engagement, and quality of life The Slinic monthly check-in at this stage typically reviews whether to continue escalation to 15mg or to maintain at 12.5mg What the data shows: Cumulative weight loss at 20 weeks in SURMOUNT-1 was approximately 1719% for the highest dose group
While some animal studies have suggested a potential risk, human studies are inconclusive, and the has approved tirzepatide for use in humans
Originally designed for Type 2 diabetes, these drugs help people keep their blood sugar in check
Both medications will be active simultaneously for several weeks
However, indirect interactions may occur through overlapping physiological effects
Strom BL, Schinnar R, Apter AJ, et al
